Molecular chaperones. Biology and prospects for pharmacological intervention

David F. Smith, Luke Whitesell, Emmanuel Katsanis

Research output: Contribution to journalArticle

180 Citations (Scopus)

Abstract

In this review, we have presented an overview of protein misfolding as a basis for disease and have provided a prospective look at pharmacological approaches that may ultimately help to prevent or resolve protein-folding problems. Much of this article has focused on the molecular and chemical chaperons that assist in protein-folding processes and may be helpful in alleviating conditions that result from misfolding. A textbook-length treatise would be needed to fully cover these subjects, and we apologize for our oversights and biases in selecting the topics, examples, and citations that appear here. Currently, there are few pharmacological therapies that directly address protein misfolding and chaperone activity, so much of our outlook is necessarily speculative. Although some of our prognostications may prove to be inaccurate or unfeasible, perhaps for reasons we should have recognized, we would be surprised if chaperone-targeting drugs, including ones unforeseen by us, are not added to the clinical arsenal in the near future.

Original languageEnglish (US)
Pages (from-to)493-513
Number of pages21
JournalPharmacological Reviews
Volume50
Issue number4
StatePublished - 1998

Fingerprint

Molecular Chaperones
Protein Folding
Pharmacology
Textbooks
Drug Delivery Systems
Proteins
Therapeutics

ASJC Scopus subject areas

  • Pharmacology

Cite this

Molecular chaperones. Biology and prospects for pharmacological intervention. / Smith, David F.; Whitesell, Luke; Katsanis, Emmanuel.

In: Pharmacological Reviews, Vol. 50, No. 4, 1998, p. 493-513.

Research output: Contribution to journalArticle

Smith, David F. ; Whitesell, Luke ; Katsanis, Emmanuel. / Molecular chaperones. Biology and prospects for pharmacological intervention. In: Pharmacological Reviews. 1998 ; Vol. 50, No. 4. pp. 493-513.
@article{6ae599646d3f42aba935893c4e2707fb,
title = "Molecular chaperones. Biology and prospects for pharmacological intervention",
abstract = "In this review, we have presented an overview of protein misfolding as a basis for disease and have provided a prospective look at pharmacological approaches that may ultimately help to prevent or resolve protein-folding problems. Much of this article has focused on the molecular and chemical chaperons that assist in protein-folding processes and may be helpful in alleviating conditions that result from misfolding. A textbook-length treatise would be needed to fully cover these subjects, and we apologize for our oversights and biases in selecting the topics, examples, and citations that appear here. Currently, there are few pharmacological therapies that directly address protein misfolding and chaperone activity, so much of our outlook is necessarily speculative. Although some of our prognostications may prove to be inaccurate or unfeasible, perhaps for reasons we should have recognized, we would be surprised if chaperone-targeting drugs, including ones unforeseen by us, are not added to the clinical arsenal in the near future.",
author = "Smith, {David F.} and Luke Whitesell and Emmanuel Katsanis",
year = "1998",
language = "English (US)",
volume = "50",
pages = "493--513",
journal = "Pharmacological Reviews",
issn = "0031-6997",
publisher = "American Society for Pharmacology and Experimental Therapeutics",
number = "4",

}

TY - JOUR

T1 - Molecular chaperones. Biology and prospects for pharmacological intervention

AU - Smith, David F.

AU - Whitesell, Luke

AU - Katsanis, Emmanuel

PY - 1998

Y1 - 1998

N2 - In this review, we have presented an overview of protein misfolding as a basis for disease and have provided a prospective look at pharmacological approaches that may ultimately help to prevent or resolve protein-folding problems. Much of this article has focused on the molecular and chemical chaperons that assist in protein-folding processes and may be helpful in alleviating conditions that result from misfolding. A textbook-length treatise would be needed to fully cover these subjects, and we apologize for our oversights and biases in selecting the topics, examples, and citations that appear here. Currently, there are few pharmacological therapies that directly address protein misfolding and chaperone activity, so much of our outlook is necessarily speculative. Although some of our prognostications may prove to be inaccurate or unfeasible, perhaps for reasons we should have recognized, we would be surprised if chaperone-targeting drugs, including ones unforeseen by us, are not added to the clinical arsenal in the near future.

AB - In this review, we have presented an overview of protein misfolding as a basis for disease and have provided a prospective look at pharmacological approaches that may ultimately help to prevent or resolve protein-folding problems. Much of this article has focused on the molecular and chemical chaperons that assist in protein-folding processes and may be helpful in alleviating conditions that result from misfolding. A textbook-length treatise would be needed to fully cover these subjects, and we apologize for our oversights and biases in selecting the topics, examples, and citations that appear here. Currently, there are few pharmacological therapies that directly address protein misfolding and chaperone activity, so much of our outlook is necessarily speculative. Although some of our prognostications may prove to be inaccurate or unfeasible, perhaps for reasons we should have recognized, we would be surprised if chaperone-targeting drugs, including ones unforeseen by us, are not added to the clinical arsenal in the near future.

UR - http://www.scopus.com/inward/record.url?scp=0032416104&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032416104&partnerID=8YFLogxK

M3 - Article

C2 - 9860803

AN - SCOPUS:0032416104

VL - 50

SP - 493

EP - 513

JO - Pharmacological Reviews

JF - Pharmacological Reviews

SN - 0031-6997

IS - 4

ER -